DBV TECHNOLOGIES News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.01.22	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
12.01.22	Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021 (GlobeNewswire)
07.01.22	DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference (GlobeNewswire)
20.12.21	DBV Technologies Provides Update on Investigational Viaskin™ Peanut (GlobeNewswire)
10.12.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2021 (GlobeNewswire)
24.11.21	DBV Technologies to Participate in an Upcoming Investor Conference (GlobeNewswire)
04.11.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2021 (GlobeNewswire)
01.11.21	DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021 (GlobeNewswire)
26.10.21	DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments (GlobeNewswire)
12.10.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021 (GlobeNewswire)
08.09.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2021 (GlobeNewswire)
31.08.21	DBV Technologies to Participate at Upcoming Investor Conferences (GlobeNewswire)
09.08.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2021 (GlobeNewswire)
06.08.21	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
02.08.21	DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments (GlobeNewswire)
31.07.21	Ausblick: DBV TECHNOLOGIES präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
26.07.21	DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021 (GlobeNewswire)
18.07.21	Erste Schätzungen: DBV TECHNOLOGIES gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
07.07.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021 (GlobeNewswire)
15.06.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2021 (GlobeNewswire)
02.06.21	DBV Technologies to Present at Upcoming Investor Conferences (GlobeNewswire)
19.05.21	DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its (GlobeNewswire)
17.05.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2021 (GlobeNewswire)
05.05.21	DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021 (GlobeNewswire)
03.05.21	DBV Technologies Reports Q1 2021 Financial Results (GlobeNewswire)
01.05.21	Ausblick: DBV TECHNOLOGIES stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
29.04.21	DBV Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
28.04.21	Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
28.04.21	Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic (GlobeNewswire)
18.04.21	Erste Schätzungen: DBV TECHNOLOGIES gewährt Anlegern Blick in die Bücher (finanzen.net)
02.04.21	DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors (GlobeNewswire)
02.04.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021 (GlobeNewswire)
26.03.21	DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual General Meeting (GlobeNewswire)
17.03.21	DBV Technologies Announces Filing of 2020 Annual Report on Form 10-K and 2020 Universal Registration Document (GlobeNewswire)
12.03.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2021 (GlobeNewswire)
11.03.21	DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments (GlobeNewswire)
05.03.21	DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference (GlobeNewswire)
04.03.21	DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results (GlobeNewswire)
01.03.21	DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021 (GlobeNewswire)
24.02.21	DBV Technologies to Participate in Upcoming AAAAI 2021 Congress (GlobeNewswire)
22.02.21	DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer (GlobeNewswire)
19.02.21	DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference (GlobeNewswire)
11.02.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021 (GlobeNewswire)
29.01.21	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
14.01.21	DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years (GlobeNewswire)
07.01.21	DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process (GlobeNewswire)
05.01.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020 (GlobeNewswire)
15.12.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020 (GlobeNewswire)
24.11.20	DBV Technologies Announces Leadership Changes (GlobeNewswire)
11.11.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu DBV TECHNOLOGIES

Aktien Top/Flop

Meistgelesene Nachrichten